News

In addition to his legacy in advancing cancer therapeutics, Scripps Research scientists know him as a determined scientist and skilled mentor.

A molecule in hoppy beers, like IPAs, appears to fuel weight loss and have benefits for type 2 diabetes in mice. But how?

A new four-year, $3 million grant will enable scientists to advance compounds that may protect neurons in diseases including Parkinson’s, ALS, Alzheimer’s and Creutzfeldt-Jakob disease.

“This would be the first compound to directly target the motivational power of craving triggers.”

"In an age where scientific results are being constantly questioned, open data has become an essential part the discovery process."

“This is like understanding how to kill five or six birds with one stone,” says Erica Ollmann Saphire, PhD, professor at Scripps Research.

The findings suggest these vaccines could increase chances of recovery in cases where a drug therapy alone is not working.

"Pregnant women are curious about their health. They want to understand what is normal for women like them..."

New Scripps Research method may help.

Scripps Research is Science Changing Life

The new test could give public health officials and doctors critical information for tracking river blindness outbreaks and treating current infections.

"I'm surprised and honored to be listed among the distinguished awardees," says Shenvi.

Yates’s research in mass spectrometry has been fundamental in establishing the field of large-scale proteomics, a discipline that has shed light on diseases such as malaria and anthrax.

With new funding, researchers aim to control pain without the risk of addiction.

Scientists at Scripps Research have solved the structure of a key protein that senses when our cells swell.

Neuroscientist Candice Contet and colleagues to take a close look how an understudied brain region promotes alcohol drinking.

"This opens up new options for treating diseases of the blood."

An unexpected discovery in two disease-linked proteins could shed light on human immune system disorders, including a rare and often fatal childhood disease.

This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.

Scripps Research scientists have developed a powerful new strategy for synthesizing molecular skeletons of chemicals used in drugs and other important products

Scientists have discovered that a microscopic roundworm develops similar nerve damage to human patients when their muscle cells are genetically engineered to produce TTR proteins.

"We can now watch antibody responses evolve almost in real time."

New method for precisely controlling 3D architecture of critical linkages used in potential therapeutics.

"This could give us a way to kill tumors without harming normal cells..."